Applications for Liver Organoids in Basic Tissue Science and Medicine

Heaven Nevaeh^*
*Correspondence: Heaven Nevaeh, Department of Tissue Science, University of Portland, N Willamette Blvd, Portland, OR, USA, Email:

Description

The liver is the body's most crucial digesting organ. Numerous have looked into the biology of the liver and liver-related illnesses. However, the majority of these have only looked at two-dimensional cell lines and animal models to examine liver formation, mechanisms of liver regeneration, and the pathophysiology of liver diseases. Animal models are constrained by interspecies variances, while conventional 2D cell lines do not accurately depict the intricate three-dimensional tissue architecture. These flaws restrict our understanding of the biology and diseases of the liver. The use of liver organoid technology helps to clarify the morphological, physiological, and fundamental tissue-level functions of liver tissue [1].

Single type cell culture produces liver organoids. Such as adult stem cells, primary hepatocytes, primary cholangiocytes, induced pluripotent stem cells, and multi-type cells co-culture, such as hepatic endoderm cells produced from iPSCs co-cultured with mesenchymal stem cells and umbilical cord-derived endothelial cells. According to studies, liver organoids are a promising model for personalised medicine, drug testing, organogenesis, liver regeneration, disease modelling, and regenerative medicine. A useful model for developing basic research and clinical therapeutic strategies for hepatopathy is liver organoids.

An essential metabolic organ found in the abdominal cavity is the liver. Metabolic, synthetic, immunologic, and detoxifying activities are only some of the functions it performs. The liver has a strong ability for regeneration. liver disease, liver cancer, Due to a lack of donor livers and a lack of knowledge about the mechanisms underlying liver illness, genetic inherited disorders and viral hepatitis cause over 2 million deaths annually worldwide. As a result, research on liver aetiology, regeneration, and development is crucial for regenerative medicine and disease treatment. Numerous studies are now investigating various cell and animal models. Long-term and steady expansion places a limit on conventional two-dimensional culture [2].

Primary hepatocytes gradually lose specialised functions and go through morphological changes in 2D culture, where they eventually perish. Furthermore, the complex three-dimensional architecture and cellular heterogeneity of liver tissue are not replicated by 2D culture. Additionally, it lacks the connections between cells and the extracellular matrix that are necessary for sustaining in biological processes, in-situ phenotypes, and tissue-specific cellular activities. The creation of animal models requires a lot of labour, resources, and time. Animal ethics as well as interspecies phenotypic and genetic traits limit the use of animal models.

The study of extracellular matrix biology has advanced, allowing for the exploration of mechanisms governing self-organization and organoid culture systems as well as a better knowledge of signalling pathways regulating stem cell niches and differentiation. Organ analogues, also known as organoids, are thought to arise from 3D cells when they self-organize to imitate the spatial, physiological, and functional properties of an organ. The structure, physiology, and genetic integrity of an organoid can be steadily maintained over a period of months in culture after a number of generations. This employs the definition of liver organoids provided by and Takebe, that single type cell culture and multi-type cell co-culture are the sources of liver organoids. It is also possible to create liver tumour organoids using primary liver tumour cells. Technology connected to organoids has profoundly altered liver-related. This explores and summarises the many organogenesis, liver regeneration, disease modelling, drug screening, and individualised therapeutic applications as well as the production methodologies of liver organoid [3].

The liver organoid technology reproduces in a dish the morphological, physiological, and fundamental tissue-level functions of liver tissue. Selforganization of the cell population plays a major role in the creation of organoids. Under a consistent signalling environment, cell populations can selforganize and spatially reorganise to form an ordered structure. This process closely resembles the formation of the liver. When the liver develops, bipotent In the presence of signalling molecules such as hepatocyte growth factor, bone morphogenetic protein, and fibroblast growth factor, liver progenitors with the capacity to differentiate into hepatocytes and cholangiocytes go through morphogenetic processes to create liver buds. The creation of liver organoids depends critically on the culture environment, the signal, and the types of beginning cells.

3D extracellular matrix with biological features is provided by culture environment. Extracellular molecules make up the ECM, which creates a 3D microenvironment and supports biochemical signalling to promote cell adhesion and proliferation. In order to support liver organoid cultivation, hydrogels are frequently used. The most popular matrix for producing liver organoids is commercial matrigel, a natural ECM derived from Engelbreth- Holm-Swarm mouse sarcoma. Additionally, decellularized tissues such the small intestine matrix and liver have been used to create ECM hydrogel. to support liver organoid culture, been studied. In addition to imitating the ECM's structure and microenvironment and preserving a milieu of proteins, growth factors, and cytokines that gives cells mechanical, biophysical, and biochemical cues, natural hydrogels have a number of other advantages [4].

However, it is challenging to regulate the uniformity and reproducibility of large-scale organoid synthesis because complex and varied elements are not chemically defined. Additionally, because matrigel is made from EHS mouse sarcoma, it hinders the advancement of therapeutic applications and subsequent organoid growth processes. Intestinal, brain, and hepatic organoid cultures have been supported by the introduction of chemically specified hydrogels. Synthetic hydrogels have a number of benefits, including Good Manufacturing Practices compliance, uniformity, and predictable mechanical qualities. However, they are constrained by the absence of biological signals and natural matrices. It has been claimed that polyethylene glycol hydrogel can imitate the physical and biological features of the liver microenvironment by controlling the mechanical qualities, hence promoting the production of intestinal organoids. To enhance biological functions, PEG hydrogels can be easily modified with collagen, fibronectin, laminin, and peptide.

The initial cell population starts to organise itself in the particular signalling environment during the creation of liver organoids. To encourage selforganization, however, exogenous signals linked to liver development should be given. Wnt, FGF, BMP, and other signals are used to induce the formation of the liver bud from the foregut endoderm. Anterior endodermal progenitors are encouraged to take on hindgut destinies by overactivation of the Wnt pathway, which prevents the production of liver cells. Additionally, many cues can drive the differentiation by activating or inhibiting the signalling pathways of organ development. pluripotent stem cell direction.

The properties of the final liver organoid are determined by the initial cell types. Adult stem cells PHs, native or iPSC-derived hepatic endoderm cells, mesenchymal stem cells, and endothelial cells from the umbilical cord are co-cultured to produce liver organoids. Additionally, original liver tumour cells can be used to create liver tumour organoids. In biomedical applications procedures for production of liver organoids, picking the appropriate starting cell types is crucial since the different starting cell types take distinct routes. You can categorise the methods for creating liver organoids into co-cultures of different types of cells and single-type cell culture.

The proliferation and self-organization of homogeneous cell populations are ensured by liver organoids created from a single cell type. Starting cells employed in this process include iPSCs, ASCs, PHs, and PCs. generate organoids of the liver. It is frequently necessary to further differentiate iPSCand ASC-derived liver organoids into mature hepatocyte or hepatobiliary organoids. Yamanaka successfully obtained reprogrammed pluripotent stem cells with a high degree of similarity to embryonic stem cells in terms of gene and protein expression profiles, proliferation, and differentiation characteristics by transferring Oct3/4, Sox2, c-Myc, and Klf4 into differentiated fibroblasts. IPSCs can differentiate into a multitude of cell types employing particular differentiation techniques and have a limitless capacity for self-renewal. Therefore, in the field of regenerative medicine, iPSCs are regarded as the most efficient source of donor cells.

Gastrulation is crucial to the development of the embryo. Under the influence of particular signalling molecules, the gastrula further divides into the three germ layers of endoderm, mesoderm, and ectoderm. Endoderm is the source of liver progenitors. To simulate liver development, iPSCs can be differentiated into definitive endoderm and effectively created liver organoids with sustained mature hepatic features. In alternative hypoxic and normoxic environments, iPSCs differentiated into endoderm and further demonstrated hepatic development. Then, liver organoids were created on top of 2D hepatocyte monolayers. For culture and amplification, the floating cysts were collected and placed in matrigel. The liver organoids were successively passaged and expanded in the expansion media at this stage since they still possessed stem cell characteristics and demonstrated hepatic function [5].

After displaying more mature traits of functional hepatocytes, the liver organoids were cultured in differentiation media for further maturation. According to several, human liver stem/progenitor cells used to create liver organoids as a marker beginning with endodermal cells. Organoids of the liver were produced there. The liver organoids were enlarged over while keeping their ability to differentiate and expand effectively. The liver organoids were introduced so that they may develop into mature hepatocytes. Developed cholangiocyte organoids made from hepatoblasts obtained from humans. Through the use of developmentally appropriate proteins, hepatoblasts grown with stromal cells produced a protein that resembled signalling, promoting effective cholangiocyte differentiation and aggregation formation in matrigel coated plates. To create organoids, the 3D aggregates were next immersed in a collagen and matrigel solution containing epidermal growth factor. Organoids made out of cholangiocytes showed ductal and/or cyst features. In order to create functioning cholangiocyte organoids, established cholangiocyte organoids from -derived cholangiocyte progenitors CPs were embedded in matrigel.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Olgasi, Cristina, Alessia Cucci and Antonia Follenzi. "iPSC-derived liver organoids: A journey from drug screening, to disease modeling, arriving to regenerative medicine." Int J Mol Sci 21 (2020): 6215.

Google Scholar, Crossref, Indexed at

2. Zhu, Xinglong, Bingqi Zhang, Yuting He and Ji Bao. "Liver organoids: Formation strategies and biomedical applications." Tissue Eng Regen Med 18 (2021): 573-585.

Google Scholar, Crossref, Indexed at

3. Prior, Nicole, Patricia Inacio and Meritxell Huch. "Liver organoids: From basic research to therapeutic applications." Gut 68 (2019): 2228-2237.

Google Scholar, Crossref, Indexed at

4. Ye, Shicheng, Jochem WB Boeter, Marko Mihajlovic and Frank G. van Steenbeek, et al. "A chemically defined hydrogel for human liver organoid culture." Adv Funct Mater 30 (2020): 2000893.

Google Scholar, Crossref, Indexed at

5. Harrison, Sean Philip, Saphira Felicitas Baumgarten, Rajneesh Verma and Oleg Lunov, et al. "Liver organoids: Recent developments, limitations and potential." Front Med 8 (2021): 574047.

Google Scholar, Crossref, Indexed at